Screening for and treatment of left-ventricular abnormalities in diabetes mellitus

Lancet. 2002 Oct 19;360(9341):1251-2; author reply 1252. doi: 10.1016/S0140-6736(02)11255-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Diabetes Complications*
  • Diabetes Mellitus / blood
  • Heart Failure / blood
  • Heart Failure / etiology
  • Heart Failure / prevention & control*
  • Humans
  • Hypertrophy, Left Ventricular* / blood
  • Hypertrophy, Left Ventricular* / diagnosis
  • Hypertrophy, Left Ventricular* / drug therapy
  • Mass Screening*
  • Metalloendopeptidases / antagonists & inhibitors
  • Natriuretic Peptide, Brain / blood*
  • Pyridines / therapeutic use
  • Thiazepines / therapeutic use
  • Ventricular Dysfunction, Left* / blood
  • Ventricular Dysfunction, Left* / diagnosis
  • Ventricular Dysfunction, Left* / drug therapy

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Pyridines
  • Thiazepines
  • Natriuretic Peptide, Brain
  • omapatrilat
  • Metalloendopeptidases